Related Experiment Video
Updated: Aug 29, 2025

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
Reoccurrence of takotsubo cardiomyopathy induced by osimertinib: A case report
Yuko Fukuda1, Yoshitaka Kawa2, Akiko Nonaka1
1Division of Onco-cardiology Hyogo cancer center Akashi Japan.
Abstract:
A patient with lung cancer was administrated osimertinib. She developed symptomatic heart failure due to Takotsubo cardiomyopathy (TC). As her condition improved after discontinuing osimertinib, TC was thought to be caused by osimertinib. Reoccurrence of TC was seen after readministrating half dose of osimertinib.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure III: Clinical Manifestations
Cardiomyopathy I: Introduction and Classification
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

